drugset / Trial / NCT06935747
Osteogenic Action of a Medical Device Based on Beta-tricalcium Phosphate (BTCP)
Phase 4
Not yet recruiting
30 enrolled
Mario Pérez Sayáns
Nueva Galimplant SLU · collabUniversidad de Murcia · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The general objective of this split-mouth study is to analyze the osteogenic action of BTCP during the bone regeneration process following the extraction of impacted mandibular third molars.
Timeline
- Start
- 2025-07
- Primary completion
- 2026-03
- Completion
- 2026-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bovine Hydroxyapatite | Other / unclassified | — | — |
| Subject | beta-tricalcium phosphate | Other / unclassified | — | — |